Catalyst Wire Dossier Catalyst Wire Dossier

Rofecoxib

rofecoxib · Merck & Co.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Rofecoxib, covering 2011-08-22 to 2023-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC [Phase 2, Phase 3]

See pricing